For decades, the WABC newscaster encouraged other families facing the disease to hold onto hope. Now, he finds himself ...
The FDA is allowing MMI to enroll more patients in a feasibility trial studying use of the Symani robot for microsurgery to ...
Bipartisan legislation would require insurers to cover FDA-approved medications that significantly slow disease progression, ...
Dan Schwinnen doesn’t see himself as particularly gullible, but in a desperate attempt to obtain some medical relief in his mother-in-law’s battle against Alzheimer’s Disease, he took a ...
The U.S. Food and Drug Administration (FDA) recently approved Leqembi, a drug indicated to treat Alzheimer’s disease in patients with mild cognitive impairment. The FDA granted Leqembi an Accelerated ...
A new study shows ImmunoBrain anti-PD-L1 antibody IBC-Ab002 is safe and reduces neurodegenerative biomarkers in Alzheimer's.
Valiltramiprosate, a drug in development as a disease-modifying therapy for Alzheimer’s disease, showed rapid and sustained ...
A 2024 report of a severe Alzheimer's disease patient who improved after an intravenous mesenchymal stem cell transplant was ...
Sara Whitney has been married to Bruce Whitney for 20 years. When Bruce was diagnosed with early-onset Alzheimer’s disease at ...
People who lived within 50 km of a coal-fired power plant were 72.9% more likely to develop Alzheimer’s disease pathology ...
Readers respond to a Science Times article, “New Potential for Diagnosing Alzheimer’s Disease.” Also: The noise that data centers make.
New studies point to the power of testing for and treating tau, a protein that builds up in Alzheimer’s disease, instead of just amyloid.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results